Cargando…

TachoSil use in abdominal surgery: a review

The success of any surgical procedure is based on adequate hemostasis. Many different biomaterial products can be used to achieve that aim. The products that can be used during surgery may be classified as topical hemostats, sealants, and adhesives. Hemostats can clot blood. Sealants can create seal...

Descripción completa

Detalles Bibliográficos
Autores principales: Toro, Adriana, Mannino, Maurizio, Reale, Giulio, Di Carlo, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262340/
https://www.ncbi.nlm.nih.gov/pubmed/22287861
http://dx.doi.org/10.2147/JBM.S13061
_version_ 1782221708201033728
author Toro, Adriana
Mannino, Maurizio
Reale, Giulio
Di Carlo, Isidoro
author_facet Toro, Adriana
Mannino, Maurizio
Reale, Giulio
Di Carlo, Isidoro
author_sort Toro, Adriana
collection PubMed
description The success of any surgical procedure is based on adequate hemostasis. Many different biomaterial products can be used to achieve that aim. The products that can be used during surgery may be classified as topical hemostats, sealants, and adhesives. Hemostats can clot blood. Sealants can create sealing barriers. Adhesives bond tissue together. Collagen, gelatin, and cellulose are hemostat agents. TachoSil(®) is a development of TachoComb(®) and TachoComb(®) H. TachoComb is made with equine collagen, bovine thrombin, bovine aprotinin, and human fibrinogen. The clinical efficacy of TachoSil was shown firstly by a clinical study of hepatic surgery. In the study, TachoSil proved to be superior to argon beamer in obtaining effective and fast intraoperative hemostasis. Following the study, many applications in different fields of surgery have been reported in the literature. The use of TachoSil in open abdominal surgery and its relevant results have encouraged the use of TachoSil in laparoscopic surgery. Unfortunately, its use in laparoscopy has not become as popular as it is in open surgery, due to a lack of efficacious techniques. Immunologic reactions to compounds of TachoSil and the transmission of infectious diseases are two major risks concerning topical hemostasis. Even though the risk of severe immunologic reactions to bovine material is low, TachoSil has gradually replaced all bovine material with material of human origin and has therefore eliminated the associated risks of bovine material. TachoSil has a good satisfaction rate among surgeons and reduces both the operating time for patients and the time spent in intensive care units.
format Online
Article
Text
id pubmed-3262340
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32623402012-01-27 TachoSil use in abdominal surgery: a review Toro, Adriana Mannino, Maurizio Reale, Giulio Di Carlo, Isidoro J Blood Med Review The success of any surgical procedure is based on adequate hemostasis. Many different biomaterial products can be used to achieve that aim. The products that can be used during surgery may be classified as topical hemostats, sealants, and adhesives. Hemostats can clot blood. Sealants can create sealing barriers. Adhesives bond tissue together. Collagen, gelatin, and cellulose are hemostat agents. TachoSil(®) is a development of TachoComb(®) and TachoComb(®) H. TachoComb is made with equine collagen, bovine thrombin, bovine aprotinin, and human fibrinogen. The clinical efficacy of TachoSil was shown firstly by a clinical study of hepatic surgery. In the study, TachoSil proved to be superior to argon beamer in obtaining effective and fast intraoperative hemostasis. Following the study, many applications in different fields of surgery have been reported in the literature. The use of TachoSil in open abdominal surgery and its relevant results have encouraged the use of TachoSil in laparoscopic surgery. Unfortunately, its use in laparoscopy has not become as popular as it is in open surgery, due to a lack of efficacious techniques. Immunologic reactions to compounds of TachoSil and the transmission of infectious diseases are two major risks concerning topical hemostasis. Even though the risk of severe immunologic reactions to bovine material is low, TachoSil has gradually replaced all bovine material with material of human origin and has therefore eliminated the associated risks of bovine material. TachoSil has a good satisfaction rate among surgeons and reduces both the operating time for patients and the time spent in intensive care units. Dove Medical Press 2011-03-14 /pmc/articles/PMC3262340/ /pubmed/22287861 http://dx.doi.org/10.2147/JBM.S13061 Text en © 2011 Toro et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Toro, Adriana
Mannino, Maurizio
Reale, Giulio
Di Carlo, Isidoro
TachoSil use in abdominal surgery: a review
title TachoSil use in abdominal surgery: a review
title_full TachoSil use in abdominal surgery: a review
title_fullStr TachoSil use in abdominal surgery: a review
title_full_unstemmed TachoSil use in abdominal surgery: a review
title_short TachoSil use in abdominal surgery: a review
title_sort tachosil use in abdominal surgery: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262340/
https://www.ncbi.nlm.nih.gov/pubmed/22287861
http://dx.doi.org/10.2147/JBM.S13061
work_keys_str_mv AT toroadriana tachosiluseinabdominalsurgeryareview
AT manninomaurizio tachosiluseinabdominalsurgeryareview
AT realegiulio tachosiluseinabdominalsurgeryareview
AT dicarloisidoro tachosiluseinabdominalsurgeryareview